Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Current Deferred Revenue (2016 - 2020)

InspireMD (NSPR) has 11 years of Current Deferred Revenue data on record, last reported at $19000.0 in Q3 2020.

  • For Q3 2020, Current Deferred Revenue changed 0.0% year-over-year to $19000.0; the TTM value through Sep 2020 reached $19000.0, changed 0.0%, while the annual FY2019 figure was $20000.0, 20.0% down from the prior year.
  • Current Deferred Revenue reached $19000.0 in Q3 2020 per NSPR's latest filing, up from $17000.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $111000.0 in Q2 2016 and bottomed at $17000.0 in Q1 2020.
  • Average Current Deferred Revenue over 5 years is $30222.2, with a median of $25000.0 recorded in 2018.
  • Peak YoY movement for Current Deferred Revenue: tumbled 80.24% in 2016, then rose 25.0% in 2018.
  • A 5-year view of Current Deferred Revenue shows it stood at $33000.0 in 2016, then crashed by 39.39% to $20000.0 in 2017, then grew by 25.0% to $25000.0 in 2018, then dropped by 20.0% to $20000.0 in 2019, then dropped by 5.0% to $19000.0 in 2020.
  • Per Business Quant database, its latest 3 readings for Current Deferred Revenue were $19000.0 in Q3 2020, $17000.0 in Q2 2020, and $17000.0 in Q1 2020.